ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12496 recruiting trials
Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells
👨⚕️ Jun Shi, PhD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Aug 2023View details ↗
Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
RecruitingNCT06138340 ↗
The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma
RecruitingNCT07146425 ↗
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
👨⚕️ Mingsheng Huang, M.D. & Ph.D., Department of Interventional Radiology, The Third Affiliated Hospital of Sun Yat-sen University📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT05816954 ↗
Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS
👨⚕️ Giovanni Landoni, Professor, Università Vita-Salute San Raffaele📍 2 sites📅 Started Aug 2023View details ↗
Enrolling by InvitationNCT05962398 ↗
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
👨⚕️ Barry Greenberg, MD, University of California, San Diego📍 3 sites📅 Started Aug 2023View details ↗
Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Aug 2023View details ↗
A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)
RecruitingNCT07356817 ↗
Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
RecruitingNCT06183645 ↗
Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
RecruitingNCT05328024 ↗
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →